Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity - PubMed

Affiliations

• PMID: 16207712
• DOI: 10.1074/jbc.M506162200

Free article

Poly(ADP-ribose) polymerase-1-dependent cardiac myocyte cell death during heart failure is mediated by NAD+ depletion and reduced Sir2alpha deacetylase activity

Jyothish B Pillai et al. J Biol Chem. 2005.

Free article

Abstract

Robust activation of poly(ADP-ribose) polymerase-1 (PARP) by oxidative stress has been implicated as a major cause of caspase-independent myocyte cell death contributing to heart failure. Here, we show that depletion of myocyte NAD levels and the subsequent reduction of Sir2alpha deacetylase activity are the sequential steps contributing to PARP-mediated myocyte cell death. In both failing hearts and cultured cardiac myocytes, the increased activity of PARP was associated with depletion of cellular NAD levels and reduced Sir2alpha deacetylase activity. Myocyte cell death induced by PARP activation was prevented by repletion of cellular NAD levels either by adding NAD directly to the culture medium or by overexpressing NAD biosynthetic enzymes. The beneficial effect of NAD repletion was seen, however, only when Sir2alpha was intact. Knocking down Sir2alpha levels by small interfering RNA eliminated this benefit, indicating that Sir2alpha is a downstream target of NAD replenishment leading to cell protection. NAD repletion also prevented loss of the transcriptional regulatory activity of the Sir2alpha catalytic core domain resulting from PARP activation. We also show that PARP activation and the concomitant reduction of Sir2alpha activity in failing hearts regulate the post-translational acetylation of p53. These data demonstrate that, in stressed cardiac myocytes, depletion of cellular NAD levels forms a link between PARP activation and reduced Sir2alpha deacetylase activity, contributing to myocyte cell death during heart failure.

Similar articles

• Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy.

  Pillai JB, Gupta M, Rajamohan SB, Lang R, Raman J, Gupta MP. Pillai JB, et al. Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1545-53. doi: 10.1152/ajpheart.01124.2005. Epub 2006 Apr 21. Am J Physiol Heart Circ Physiol. 2006. PMID: 16632544

• Negative control of p53 by Sir2alpha promotes cell survival under stress.

  Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W. Luo J, et al. Cell. 2001 Oct 19;107(2):137-48. doi: 10.1016/s0092-8674(01)00524-4. Cell. 2001. PMID: 11672522

• Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.

  Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, Sadoshima J. Alcendor RR, et al. Circ Res. 2004 Nov 12;95(10):971-80. doi: 10.1161/01.RES.0000147557.75257.ff. Epub 2004 Oct 14. Circ Res. 2004. PMID: 15486319

• Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.

  Henning RJ, Bourgeois M, Harbison RD. Henning RJ, et al. Cardiovasc Toxicol. 2018 Dec;18(6):493-506. doi: 10.1007/s12012-018-9462-2. Cardiovasc Toxicol. 2018. PMID: 29968072 Review.

• Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes.

  Cantó C, Sauve AA, Bai P. Cantó C, et al. Mol Aspects Med. 2013 Dec;34(6):1168-201. doi: 10.1016/j.mam.2013.01.004. Epub 2013 Jan 25. Mol Aspects Med. 2013. PMID: 23357756 Free PMC article. Review.

Cited by

• NAD⁺ Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death.

  Xu W, Li L, Zhang L. Xu W, et al. Front Physiol. 2020 Aug 13;11:901. doi: 10.3389/fphys.2020.00901. eCollection 2020. Front Physiol. 2020. PMID: 32903597 Free PMC article. Review.

• MacroH2A1 Regulation of Poly(ADP-Ribose) Synthesis and Stability Prevents Necrosis and Promotes DNA Repair.

  Ruiz PD, Hamilton GA, Park JW, Gamble MJ. Ruiz PD, et al. Mol Cell Biol. 2019 Dec 11;40(1):e00230-19. doi: 10.1128/MCB.00230-19. Print 2019 Dec 11. Mol Cell Biol. 2019. PMID: 31636161 Free PMC article.

• Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway.

  Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, Pillai JB, Samant S, Ravindra PV, Isbatan A, Gupta MP. Pillai VB, et al. J Biol Chem. 2010 Jan 29;285(5):3133-44. doi: 10.1074/jbc.M109.077271. Epub 2009 Nov 24. J Biol Chem. 2010. PMID: 19940131 Free PMC article.

• Inherited myogenic abilities in muscle precursor cells defined by the mitochondrial complex I-encoding protein.

  Motohashi N, Minegishi K, Aoki Y. Motohashi N, et al. Cell Death Dis. 2023 Oct 19;14(10):689. doi: 10.1038/s41419-023-06192-2. Cell Death Dis. 2023. PMID: 37857600 Free PMC article.

• Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury.

  Moreno-Vinasco L, Quijada H, Sammani S, Siegler J, Letsiou E, Deaton R, Saadat L, Zaidi RS, Messana J, Gann PH, Machado RF, Ma W, Camp SM, Wang T, Garcia JG. Moreno-Vinasco L, et al. Am J Respir Cell Mol Biol. 2014 Aug;51(2):223-8. doi: 10.1165/rcmb.2012-0519OC. Am J Respir Cell Mol Biol. 2014. PMID: 24588101 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Gene Ontology

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal